Differential effects of pyrrolidine dithiocarbamate on TNF-α-mediated liver injury in two different models of fulminant hepatitis

Journal of Hepatology

Volumn 48, Issue 3, 2008, Pages 442-452

  Lu, Jin Wei ^a   Wang, Hua ^a   Yan Li, Ji ^a   Zhang, Cheng ^a   Ning, Huan ^a   Li, Xiang Yun ^a   Zhang, Heng ^a   Duan, Zi Hao ^a   Zhao, Lei ^a   Wei, Wei ^a   Xu, De Xiang ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Fulminant hepatitis; Lipopolysaccharide; Nuclear factor kappa B; Pyrrolidine dithiocarbamate; Tumor necrosis factor alpha

Indexed keywords

ALANINE AMINOTRANSFERASE; BCG VACCINE; GALACTOSAMINE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DEATH; DISEASE EXACERBATION; DISEASE MODEL; ENZYME REPRESSION; FEMALE; HEPATITIS; IMMUNOREACTIVITY; INFLAMMATORY CELL; LIVER INJURY; LIVER NECROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; FEMALE; GALACTOSAMINE; GLUTATHIONE; HEPATITIS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIVER; LIVER FAILURE, ACUTE; MICE; MICE, INBRED STRAINS; MYCOBACTERIUM BOVIS; NF-KAPPA B; NITRIC OXIDE; PYRROLIDINES; THIOCARBAMATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39149121486     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.10.014     Document Type: Article

References (47)

1. Jacob A.L., Goldberg P.K., Bloom N., Degenshein G.A., and Kozinn P.J. Endotoxin and bacteria in portal blood. Gastroenterology 72 (1977) 1268-1270
2. Fukui H., Brauner B., Bode J.C., and Bode C. Plasma endotoxin concentrations in patients with alcoholic and nonalcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 12 (1991) 162-169
3. Michie H.R., Manogue K.R., Spriggs D.R., Revhaug A., Dwyer S.I., Dinarello A., et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318 (1988) 1481-1486
4. Van Deventer S.J., Buller H.R., ten Cate J.W., Aarden L.A., Hack C.E., and Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 76 (1990) 2520-2526
5. Moulin F., Copple B.L., Ganey P.E., and Roth R.A. Hepatic and extrahepatic factors critical for liver injury during lipopolysaccharide exposure. Am J Physiol Gastrointest Liver Physiol 281 (2001) 1423-1431
6. Su G.L. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283 (2002) 256-265
7. Ferluga J. Tuberculin hypersensitivity hepatitis in mice infected with Mycobacterium bovis (BCG). Am J Pathol 105 (1981) 82-90
8. Kondo Y., Takano F., and Hojo H. Suppression of lipopolysaccharide-induced fulminant hepatitis and tumor necrosis factor production by bisbenzylisoquinoline alkaloids in bacillus Calmette-Guerin-treated mice. Biochem Pharmacol 46 (1993) 1861-1863
9. Kobayashi S., Nishihira J., Watanabe S., and Todo S. Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide. Hepatology 29 (1999) 1752-1759
10. Tsuji H., Harada A., Mukaida N., Nakanuma Y., Bluethmann H., Kaneko S., et al. Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis. Infect Immun 65 (1997) 1892-1898
11. Fujioka N., Mukaida N., Harada A., Akiyama M., Kasahara T., Kuno K., et al. Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J Leukoc Biol 58 (1995) 90-98
12. Kamijo R., Le J., Shapiro D., Havell E.A., Huang S., Aguet M., et al. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 178 (1993) 1435-1440
13. Tsutsui H., Matsui K., Kawada N., Hyodo Y., Hayashi N., Okamura H., et al. IL-18 accounts for both TNF-α- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 159 (1997) 3961-3967
14. Bopst M., Garcia I., Guler R., Olleros M.L., Rülicke T., Müller M., et al. Differential effects of TNF and LTalpha in the host defense against M. bovis BCG. Eur J Immunol 31 (2001) 1935-1943
15. Liu D.F., Wei W., and Song L.H. Upregulation of TNF-alpha and IL-6 mRNA in mouse liver induced by bacille Calmette-Guerin plus lipopolysaccharide. Acta Pharmacol Sin 27 (2006) 460-468
16. Decker K., and Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 71 (1974) 77-105
17. Galanos C., Freudenberg M.A., and Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 76 (1979) 5939-5943
18. Tiegs G., Wolter M., and Wendel A. Tumor necrosis factor is a terminal mediator in galact-hepatitis in mice. Biochem Pharmacol 38 (1989) 627-631
19. Morikawa A., Kato Y., Sugiyama T., Koide N., Chakravortty D., Yoshida T., et al. Role of nitric oxide in lipopolysaccharide-induced hepatic injury in d-galactosamines-ensitized mice as an experimental endotoxic shock model. Infect Immun 67 (1999) 1018-1024
20. Liu J., Saavedra J.E., Liu T., Song J.G., Waalkes M.P., and Keefer L.K. O(2)-Vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate protection against d-galactosamine/endotoxin-induced hepatotoxicity in mice: genomic analysis using microarrays. J Pharmacol Exp Ther 300 (2002) 18-25
21. Nagai H., Matsumaru K., Feng G., and Kaplowitz N. Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes. Hepatology 36 (2002) 55-64
22. Matsumaru K., Ji C., and Kaplowitz N. Mechanisms for sensitization to TNF-induced apoptosis by acute glutathione depletion in murine hepatocytes. Hepatology 37 (2003) 1425-1434
23. Han D., Hanawa N., Saberi B., and Kaplowitz N. Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis. Free Radic Biol Med 41 (2006) 627-639
24. Osakabe N., Yasuda A., Natsume M., Sanbongi C., Kato Y., Osawa T., et al. Rosmarinic acid, a major polyphenolic component of Perilla frutescens, reduces lipopolysaccharide(LPS)-induced liver injury in d-galactosamine (d-GalN)-sensitized mice. Free Radic Biol Med 33 (2002) 798-806
25. Wang H., Xu D.X., Lu J.W., Ning H., and Wei W. Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in d-galactosamine-sensitized mice. Toxicology 237 (2007) 49-57
26. Bruck R., Aeed H., Schey R., Matas Z., Reifen R., Zaiger G., et al. Pyrrolidine dithiocarbamate protects against thioacetamide-induced fulminant hepatic failure in rats. J Hepatol 36 (2002) 370-377
27. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106 (1980) 207-212
28. Xu D.X., Wei W., Sun M.F., Wu C.Y., Wang J.P., Wei L.Z., et al. Kupffer cells and ROS partially mediate LPS-induced down-regulation of nuclear receptor Pregnane X receptor and its target gene CYP3A in mouse liver. Free Radic Biol Med 37 (2004) 10-22
29. Grisham M.B., Johnson G.G., and Lancaster Jr. J.R. Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol 268 (1996) 237-246
30. Deryckere F., and Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16 (1994) 405
31. Yajima T., Nishimura H., Saito K., Kuwano H., and Yoshikai Y. Overexpression of interleukin-15 increases susceptibility to lipopolysaccharide-induced liver injury in mice primed with Mycobacterium bovis bacillus Calmette-Guerin. Infect Immun 72 (2004) 3855-3862
32. Liu S.F., Ye X., and Malik A.B. Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 100 (1999) 1330-1337
33. Lauzurica P., Martinez-Martinez S., Marazuela M., Gomez del Arco P., Martinez C., Sanchez-Madrid F., et al. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-alpha. Eur J Immunol 29 (1999) 1890-1900
34. Hsieh Y.H., Su I.J., Wang H.C., Chang W.W., Lei H.Y., Lai M.D., et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25 (2004) 2023-2032
35. Dey A., and Cederbaum A.I. Alcohol and oxidative liver injury. Hepatology 43 (2006) S63-S74
36. Tsuji K., Kwon A.H., Yoshida H., Qiu Z., Kaibori M., Okumura T., et al. Free radical scavenger (edaravone) prevents endotoxin-induced liver injury after partial hepatectomy in rats. J Hepatol 42 (2005) 94-101
37. Basu S. Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients. Toxicology 189 (2003) 113-127
38. Shi X., Leonard S.S., Wang S., and Ding M. Antioxidant properties of pyrrolidine dithiocarbamate and its protection against Cr(VI)-induced DNA strand breakage. Ann Clin Lab Sci 30 (2000) 209-216
39. Wang G.S., and Liu G.T. Role of nitric oxide in immunological liver damage in mice. Biochem Pharmacol 49 (1995) 1277-1281
40. Guler R., Olleros M.L., Vesin D., Parapanov R., Vesin C., Kantengwa S., et al. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J Hepatol 41 (2004) 773-781
41. Beg A.A., and Baltimore D. An essential role for NF-kB in preventing TNF-a-induced cell death. Science 274 (1996) 782-784
42. Van Antwerp D.J., Martin S.J., Kafri T., Green D., and Verma I.M. Suppression of TNF-a-induced apoptosis by NF-kB. Science 274 (1996) 787-789
43. Xu Y., Bialik S., Jones B.E., Iimuro Y., Kitsis R.N., Srinivasan A., et al. NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am J Physiol 275 (1998) C1058-C1066
44. Nagaki M., Naiki T., Brenner D.A., Osawa Y., Imose M., Hayashi H., et al. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB. Hepatology 32 (2000) 1272-1279
45. Liu S., Gallo D.J., Green A.M., Williams D.L., Gong X., Shapiro R.A., et al. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 70 (2002) 3433-3442
46. Tran-Thi T.A., Decker K., and Baeuerle P.A. Differential activation of transcription factors NF-kappa B and AP-1 in rat liver macrophages. Hepatology 22 (1995) 613-619
47. Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A.M., et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317 (2007) 121-124